Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia

Cost Effectiveness and Resource Allocation ◽

10.1186/s12962-017-0079-2 ◽

2017 ◽

Vol 15 (1) ◽

Author(s):

Xiao Jun Wang ◽

Ashwini Saha ◽

Xu-Hao Zhang

Keyword(s):

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Mass Vaccination ◽

Vaccination Program ◽

Effectiveness Analysis ◽

Universal Mass Vaccination

Download Full-text

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand

Applied Health Economics and Health Policy ◽

10.1007/s40258-018-0387-5 ◽

2018 ◽

Vol 16 (3) ◽

pp. 331-345 ◽

Author(s):

Lijoy Varghese ◽

Louise Talbot ◽

Andrea Govender ◽

Xu-Hao Zhang ◽

Bruce A. Mungall

Keyword(s):

New Zealand ◽

Cost Effectiveness ◽

Haemophilus Influenzae ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Mass Vaccination ◽

Effectiveness Analysis ◽

Universal Mass Vaccination

Download Full-text

An Updated Cost-Effectiveness Analysis of Synflorix Universal Mass Vaccination Implementation in New Zealand

Value in Health ◽

10.1016/j.jval.2016.08.713 ◽

2016 ◽

Vol 19 (7) ◽

pp. A809

Author(s):

L Varghese ◽

L Talbot ◽

A Govender ◽

B Mungall

Keyword(s):

New Zealand ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Mass Vaccination ◽

Effectiveness Analysis ◽

Universal Mass Vaccination

Download Full-text

Faculty Opinions recommendation of Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13648.471140 ◽

2006 ◽

Author(s):

Sai-Kit Lam

Keyword(s):

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Vaccination Program ◽

Varicella Vaccination ◽

Effectiveness Analysis

Download Full-text

PIN20 LONG-TERM CONSEQUENCES OF AN INTENSE RUBELLA VACCINATION PROGRAM IN FORTALEZA, BRAZIL: A COST-EFFECTIVENESS ANALYSIS

Value in Health ◽

10.1016/s1098-3015(10)75461-9 ◽

2009 ◽

Vol 12 (7) ◽

pp. A518-A519

Author(s):

M Machado ◽

DM Mota

Keyword(s):

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Vaccination Program ◽

Effectiveness Analysis ◽

Long Term Consequences ◽

Rubella Vaccination

Download Full-text

Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program–Results from a randomized controlled trial

BMC Health Services Research ◽

10.1186/s12913-015-1169-5 ◽

2015 ◽

Vol 15 (1) ◽

Author(s):

Byung-Kwang Yoo ◽

Sharon G. Humiston ◽

Peter G. Szilagyi ◽

Stanley J. Schaffer ◽

Christine Long ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Elementary School ◽

Cost Effectiveness ◽

Influenza Vaccination ◽

Controlled Trial ◽

Cost Effectiveness Analysis ◽

Vaccination Program ◽

Randomized Controlled ◽

Effectiveness Analysis

Download Full-text

PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in Russia

Value in Health ◽

10.1016/j.jval.2011.08.254 ◽

2011 ◽

Vol 14 (7) ◽

pp. A277-A278

Author(s):

V. Omelyanovsky ◽

M. Avxentyeva ◽

I. Krysanov ◽

O. Ivakhnenko ◽

S. Goryaynov ◽

...

Keyword(s):

Human Papillomavirus ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Vaccination Program ◽

Human Papillomavirus Vaccination ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Universal Haemophilus Influenzae Type B (HIB) Vaccination Program in Taiwan

American Journal of Epidemiology ◽

10.1093/aje/163.suppl_11.s133-a ◽

2006 ◽

Vol 163 (suppl_11) ◽

pp. S133-S133

Author(s):

H F Tan ◽

HF Tseng

Keyword(s):

Cost Effectiveness ◽

Haemophilus Influenzae ◽

Cost Effectiveness Analysis ◽

Vaccination Program ◽

Haemophilus Influenzae Type ◽

Haemophilus Influenzae Type B ◽

Type B ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands

Vaccine ◽

10.1016/j.vaccine.2020.05.031 ◽

2020 ◽

Vol 38 (30) ◽

pp. 4687-4694 ◽

Author(s):

Joost J.M. Simons ◽

Nora Vida ◽

Tjalke A. Westra ◽

Maarten J. Postma

Keyword(s):

Human Papillomavirus ◽

Cost Effectiveness ◽

The Netherlands ◽

Cost Effectiveness Analysis ◽

Vaccination Program ◽

Human Papillomavirus Vaccination ◽

Effectiveness Analysis ◽

Download Full-text

Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2015.1011561 ◽

2015 ◽

Vol 11 (4) ◽

pp. 884-896 ◽

Author(s):

Emmanuelle Préaud ◽

Mathieu Uhart ◽

Katharina Böhm ◽

Pamela Aidelsburger ◽

Delphine Anger ◽

...

Keyword(s):

Herpes Zoster ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Vaccination Program ◽

Post Herpetic Neuralgia ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of a Shingles Vaccination Program to Prevent Herpes Zoster And Post- Herpetic Neuralgia in the Spanish Setting

Value in Health ◽

10.1016/j.jval.2014.08.2511 ◽

2014 ◽

Vol 17 (7) ◽

pp. A676

Author(s):

M.J. Álvarez Pasquín ◽

R. Cisterna ◽

A. Gil de Miguel ◽

J.L. López-Belmonte ◽

E. Préaud ◽

...

Keyword(s):

Herpes Zoster ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Vaccination Program ◽

Post Herpetic Neuralgia ◽

Effectiveness Analysis

Download Full-text